Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
THERMO FISHER SCIENTIFIC INC. entered into Twenty-Seventh Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. valued at $2,950,000,000 aggregate principal amount (effective 2023-08-10).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- The Bank of New York Mellon Trust Company, N.A.
- Value
- $2,950,000,000 aggregate principal amount
- Effective
- 2023-08-10
Exact text from the filing
On August 10, 2023, Thermo Fisher Scientific Inc. (the “Company”) issued $600,000,000 aggregate principal amount of 4.953% Senior Notes due 2026 (the “2026 Notes”), $750,000,000 aggregate principal amount of 4.977% Senior Notes due 2030 (the “2030 Notes”), $1,000,000,000 aggregate principal amount of 5.086% Senior Notes due 2033 (the “2033 Notes”) and $600,000,000 aggregate principal amount of 5.404% Senior Notes due 2043 (the “2043 Notes” and, together with the 2026 Notes, the 2030 Notes and the 2033 Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3 (File No. 333-263034) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission.
View on SEC.gov